Article Details
Retrieved on: 2022-09-20 19:42:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca Plc alleges that generic Brilinta doses proposed by Alembic Pharmaceuticals Ltd. infringe a patent for the blood thinner used to treat ...
Article found on: news.bloomberglaw.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here